Latest Thailand News

Hastings Technology Metals has accelerated its downstream rare earths strategy by progressing a 49% stake in a Thai hydrometallurgical plant, securing feedstock and doubling planned capacity. An updated Yangibana DFS reveals robust economics, underpinning near-term production and cash flow.

Kingsgate Consolidated has marked a major milestone at its Chatree Gold Mine, surpassing 200,000 ounces of gold production since March 2023. Meanwhile, remediation on Plant 1 progresses steadily, with partial operations maintaining output amid ongoing repairs.

Flagship Minerals has received full payment of US$4 million for its RK Lithium Project sale, advancing its strategic pivot towards gold and copper assets in Chile and Canada.

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

Kingsgate Consolidated has successfully restarted Plant 1 at its Chatree Gold Mine at around 50% capacity using a modified circuit while fast-tracking repairs to the Ball Mill. Mining operations continue uninterrupted, supporting ongoing production at Plant 2.

Orthocell Ltd delivered a standout FY26 with 44% revenue growth to A$13.2 million, powered by accelerating US sales of its nerve repair product Remplir and a robust cash position supporting further expansion.

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.

Adrad Holdings is investing $3 million to build a second factory in Thailand, aiming to boost capacity for its Heat Transfer Solutions business and streamline operations.

Foresta Group Holdings has received allowance from the USPTO for its US patent application covering its proprietary rosin and terpene production process, expected to protect its technology until at least 2041.

Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.

Memphasys has locked in a three-year exclusive distribution agreement for its Felix™ sperm separation system in Thailand, targeting a key IVF market with 110 clinics and 20,000–30,000 cycles annually. The deal adds approximately A$430,500 in contracted revenue, lifting South-East Asian minimum contracts to about A$1 million and contributing to FY2026 Felix™ sales now exceeding A$3 million.

Flagship Minerals has agreed to sell its RK Lithium Project in Thailand for US$4 million, accelerating its strategic pivot towards gold and copper assets in Chile and Canada.